Envveno Medical Corp NVNO

$8.10 +0.06 (0.75%)

Valuation

Market cap
5,628,000
Revenue TTM
$0
Net income TTM
$-19,470,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
24,200
Avg volume
21,086
Day's range
$7.70 – $8.78
Shares out
695,000
Stochastic %K
23%
Beta
1.29
Analysts
Sell
Price target
$30.00

Price

Company profile

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an ope...

Show more

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Industry
Medical Devices
Sector
Healthcare
Phone
949 261 2900
Website
https://www.envveno.com
Address
70 Doppler, Irvine, United States

Latest news

No headlines yet.